Cite

    Marangi, A. et al. (2022). Good response to rituximab in chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids presenting as tumor‐like infratentorial lesion. Clinical & experimental neuroimmunology. 13 (2), pp. 102-105. [Online].